Topic: Cancer
Southern California Regional Cytogenetics & Molecular Genetics Meeting Proves to be Big Success
The Southern California Regional Cytogenetics & Molecular Genetics Meeting last week was a big success. Some of the biggest names in the space attended and were able to provide feedback on the unique cases that were presented, what tools seem to work best, and how they would approach the issue.
Another Successful ACC Conference
Another successful ACC event. The ACC conference is a great way to really connect with the thought leaders in the cytogenetic community. Read this blog to get the conference highlights!
Welcome back to everyone who visited us at AMP 2017
We showed the benefits of an integrated review of CNV, AOH, and SNV using our NxClinical software which handles both array and NGS data in a single system.
Cancer statistics in males and females
The US cancer statistics for 2017 were published early this year. Cancer statistics comparison between males and females seems to be the most interesting one.
Cancer Liquid Biopsy Gains Momentum
Cancer screening for circulating tumor DNA (ctDNA) in the bloodstream, Liquid Biopsy, is a fast growing market.
Patent application for methods for prognosticating brain tumors uses Nexus Copy Number and TCGA Premier
Cedar Sinai Medical Center in Los Angeles, CA has filed a patent for a method for prognosticating patient survival based on the ZEB1 gene. The application also describes methods for selecting therapies based on analysis of ZEB1 and several other genes.
Nexus Copy Number – Casting a Wide Net
Nexus Copy Number has been used to work on a variety of organisms, including canines, monkeys, plants, humans, and more. View these highlighted publications.
BioDiscovery invited to exhibit NxClinical software with Philips at AMP 2016
BioDiscovery was invited as a partner to exhibit its NxClinical software with Philips at the American Molecular Pathology (AMP) Annual Conference. BioDiscovery's NxClinical has been an established software tool in clinical labs for copy number variants analysis and reporting.
Recent Advances in Clinical Genetics Uncovered Causative Alterations for Several Rare Diseases
Research advances in clinical genetics recently uncovered the causative alterations for several rare diseases. Evaluate your clinical samples with ease for copy number alteration, sequence variants or both using NxClinical 3.0.
Patent Filed using Nexus Copy Number – for Canine Cancer Diagnosis
Dr. Breen of North Carolina State University has been a long time user of our Nexus Copy Number software and we were pleased to learn of his application of his latest patent: a new, non-invasive method of diagnosing bladder cancer in dogs.
- BioDiscovery, Inc.
- 715 North Douglas Street
- El Segundo, CA 90245
- Tel: (310) 414-8100
- Fax: (310) 414-8111
© 2018 BioDiscovery. All rights reserved.